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Abstract
Rationale, aims and objectives Magnetic resonance imaging (MRI) is widely used in
stroke evaluation and is superior to computed tomography for the detection of acute
ischaemia. We sought to evaluate the evidence that conventional MRI influences doctor
management or patient outcomes in routine care.
Methods We systematically searched PubMED, EMBASE and proceedings of the Inter-
national Stroke Conference. Studies were included if they included patients presenting with
possible stroke syndromes and they reported MRI results and resulting changes in man-
agement or outcome. Multiple reviewers determined inclusion/exclusion for each study,
abstracted study characteristics and assessed study quality.
Results Of 1813 articles screened, nine studies met inclusion criteria. None were rand-
omized controlled trials, cohort studies or case-control studies. We found little evidence
that MRI affects outcomes – one single-centre case series presented three patients. The
remaining articles were studies of diagnostic tests or vignette-based studies that described
changes in doctor management attributed to MRI.
In the studies that suggested MRI influenced management, it did so in two ways. First,
MRI distinguished stroke from mimics (e.g. brain tumours), thus enabling more appropri-
ate selection of therapies. Second, even when MRI confirmed a suspected stroke diagnosis,
it sometimes provided information (on stroke mechanism, localization, timing or patho-
physiology) that influenced management.
Conclusions The impact of MRI on management and outcomes in stroke patients has been
inadequately studied. Further research is needed to understand how MRI may productively
affect stroke management and outcomes.
Introduction
Stroke is common [1] and is responsible for substantial disability
[2,3] and costs [4]. The use of magnetic resonance imaging (MRI)
in the diagnosis and management of stroke has substantially
increased over the last decade [5].
Stroke patients typically require a neuroimaging study, either
computed tomography (CT) or MRI, to differentiate ischaemic
stroke from intracerebral haemorrhage [6]. When the diagnosis of
stroke is uncertain, MRI is the more informative of the two
imaging modalities [7–11]. When the diagnosis of stroke is rea-
sonably certain, however, the value of MRI (in addition to or
instead of CT) is less clear. In principle, MRI-derived information
about stroke mechanism [12–14], localization [15,16], timing
[17–20] and pathophysiology [21] could improve decisions
regarding acute management and secondary prevention even when
the diagnosis is clear cut. This may be why in some parts of the
country, MRI is obtained on nearly all stroke patients (except those
with MRI contraindications) [5]. Utilization of MRI varies widely
between states however [5]. Given the established superiority of
MRI in cases where the diagnosis is uncertain, at least some of this
interstate variability probably reflects a lack of consensus regard-
ing the value of MRI in cases where the diagnosis of stroke can be
established clinically. Empiric evidence bearing on this issue could
help to standardize clinical practice and make it more cost-
effective. To address this question, we performed a systematic
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review of the evidence that stroke patients evaluated with MRI are
managed differently or have different outcomes than patients
evaluated with other imaging strategies.
Methods
We sought to identify all published studies documenting that con-
ventional MRI-based structural brain imaging led to changes in
patient management or outcomes, and to classify those changes.
We adhered to a pre-specified protocol detailing our search
strategy, inclusion/exclusion criteria, procedures for determining
inclusion/exclusion and quality assessment methodology using the
PRISMA guidelines for systematic reviews [22].
Study eligibility for inclusion
To be included in our review, a study had to involve patients over
the age of 18 who presented with acute stroke-like symptoms;
some subset of the patients underwent MRI imaging; and struc-
tural MRI results were reported in the paper. In addition, studies
had to either (1) describe a change in patient management that
would not have occurred had MRI not been performed or (2)
describe a change in patient outcomes in patients who underwent
MRI compared to patients who did not.
We included all studies regardless of study design with the
exception of case reports. Consequently, we included both
studies directly comparing MRI to CT as well as other studies
comparing one MRI technique to another. While studies compar-
ing MRI techniques do not enable direct inferences about the
role of MRI versus CT, we concluded that such inferences were
reasonable. If, for example, a study showed that MRI with
diffusion-weighted imaging (DWI) changed management com-
pared to MRI without, it is reasonable to infer that MRI with
DWI would change management compared to CT. We excluded
studies that only enrolled patients with transient ischaemic
attack. We also excluded studies where management changes
were based on multi-modal MRI (e.g. MRA, MR perfusion) as
opposed to structural MRI of the brain parenchyma, for two
reasons. First, we wanted to focus on the type of information that
can only be obtained with MRI – angiographic and perfusion
imaging information can also be obtained using CT-based tech-
nology and conventional angiography. Second, we wanted to
focus on the way MRI is most widely used in the community;
multi-modal MRI has limited availability in the emergency
department [23].
Information sources and search
We worked with an experienced research librarian to develop
comprehensive search strategies for studies combining three major
themes: stroke, MRI and changes in management or outcomes
(search strings available as Supporting Information Appendix S1).
PubMED and EMBASE were separately searched. All studies
available in English were included, regardless of publication date,
through 2 December 2010 (the date our search was performed). In
addition, we hand searched all published abstracts of the proceed-
ings of the International Stroke Conference (ISC) from 2001 to
2010 for other studies that might meet inclusion criteria. When
relevant abstracts were identified, full-length articles were sought
by serially searching on the first author’s name, the last author’s
name and pertinent keywords [24].
Study selection
After performing our search, one reviewer (JB) screened the
PubMED/EMBASE search results and ISC proceedings to identify
candidate abstracts, and then evaluated those abstracts to identify
articles that potentially met our inclusion/exclusion criteria. At
both stages, an article was rejected only if it clearly failed to satisfy
inclusion criteria or clearly met exclusion criteria. Next, two
authors reviewed the full text of each of the 74 non-rejected
articles to arrive at final inclusion/exclusion determinations.
Agreement between reviewers was good (kappa = 0.66, 95% CI
0.42–0.90). Disagreements were resolved by group consensus. We
categorized the nine articles that were ultimately determined to
meet our criteria into one of two groups, depending on whether the
article described changes in management or changes in outcomes
(Fig. 1).
Data extraction
In order to identify the features relevant to quality assessment, two
reviewers independently evaluated each included study and
recorded the primary research question, study design, number of
subjects included relevant to our study question, whether data was
retrospectively or prospectively acquired and the target population.
The primary summary measures were the number of patients in
whom management or outcome were changed. Differences were
resolved by consensus.
Quality assessment
We analysed each included study using a modified version of the
QUADAS tool [25]. QUADAS consists of 14 yes/no questions
that address the key components of quality in studies of diagnostic
tests. This tool has primarily been used to measure the quality of
studies of diagnostic accuracy, so we added three additional ques-
tions to capture the nature of changes in management and out-
comes in these studies.
Two reviewers evaluated each study on each QUADAS ques-
tion. Overall agreement was moderate (kappa = 0.48, 95% CI
0.35–0.61). Differences were resolved by consensus.
Results
A total of 1813 articles were identified by the search strategy. Of
these, 424 were selected for abstract review and 74 for full-text
review. Ultimately, nine articles were determined to meet full
inclusion/exclusion criteria (Fig. 1).
All nine of these articles described single-centre studies. They
incorporated a variety of study designs, targeted different patient
populations and compared different imaging strategies (e.g. CT
versus MRI; MRI with DWI versus MRI without DWI) [26–34].
In light of this heterogeneity, we reported study results narratively
and did not attempt to pool study results. Only one study, a
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three-patient case series, described changes in outcomes attributed
to MRI findings [31]. The remaining eight studies documented
instances in which MRI findings resulted in changes in doctor
management, but did not demonstrate that these changes in man-
agement affected outcomes. Further details of the included studies
are summarized in Table 1 and Supporting Information Appen-
dix S2. Figure 2 summarizes the ways in which MRI findings
altered clinical assessment and management, separated into two
broad categories: (1) situations in which MRI led to diagnostic
revision (i.e. patients whose post-MRI diagnosis differed from
their pre-MRI diagnosis); or (2) situations in which the pre-MRI
diagnosis and post-diagnosis MRI were both stroke, but the
MRI provided additional information that affected management.
Supporting Information Appendix S3 summarizes study quality.
Impact of MRI
Changes in outcomes
We identified only one study, the small case series from Waldron-
Lynch et al. [31], that described changes in outcome attributable to
MRI: three patients with presumed posterior circulation strokes
had their diagnoses changed to posterior reversible encephalopa-
thy syndrome (PRES), leading to changes in blood pressure man-
agement and favourable outcomes.
Changes in management
Change in management due to change in diagnosis
Diagnostic revision attributed to MRI was described in five studies,
four of which documented changes in management as a conse-
quence of the revised diagnoses. In the study of Kreisl et al. [32],
MRI evidence of stroke influenced the decision to initiate or change
secondary stroke prevention strategies in 14 of 66 patients with
primary brain tumours. In the series of 116 patients reported by
Shuaib et al. [26], of the 22 patients in whom MRI changed man-
agement, the change was due to revised diagnosis in two cases. One
patient with suspected stroke was started on anticoagulation when
MRI revealed unsuspected dural venous thrombosis. Another
patient was suspected to have dural venous thrombosis prior to
MRI, and a planned angiogram was averted when the MRI showed
no thrombosis. In four patients with normal MRIs presenting within
3 hours of onset, Sunshine et al. [33] withheld planned intravenous
(IV) thrombolysis when no infarct was visualized on MRI.
1813 Records after removing
duplicates
366 Records screened from
PubMED/EMBASE
58 Abstracts screened from
ISC Proceedings
74 full-text articles
assessed for eligibility
9 Articles included in
qualitative synthesis
395 Excluded
216 No reported management
change contingent on MRI findings
55 No conventional brain MRI
results reported
45 Review articles
42 Hyperacute time window
18 Not stroke presentations
6 Study not in humans
6 Full text not identified
5 Case reports
2 No adult cases
65 Excluded
52 No management changes 
contingent on MRI findings
5 Review articles
5 No conventional MRI results
2 Hyperacute time window
1 Case report
2077 Records identified by
PubMED/EMBASE search
All abstracts from
International Stroke
Conference (ISC) from
2001 to 2010
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Figure 1 Summary of inclusion/exclusion strategy.
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Change in management due to additional information
without change in diagnosis
Even in cases where the pre-MRI diagnosis and post-MRI diag-
nosis were both stroke, MRI sometimes revealed information that
led to changes in management. In some cases, the additional
information concerned stroke location (and consequently, stroke
mechanism) [27–29]. In other cases, the MRI provided direct
information regarding stroke mechanism, by differentiating haem-
orrhage from ischaemia or by demonstrating thrombus directly
[26,30]. In two other cases, the MRI permitted inferences regard-
ing stroke timing [28,34].
Three studies reported patients who were managed differently
because of the information about stroke location derived from
MRI. Schulz et al. [29] found that DWI findings changed clini-
cians’ conclusions regarding anterior versus posterior circulation
in 27 of 164 (16%) patients with mild stroke. Carotid endarterec-
tomy was performed in four of the patients for whom DWI results
changed the presumed stroke location from the posterior to the
anterior circulation, and carotid imaging was not obtained in 10
patients after DWI changed the presumed stroke location from the
anterior to the posterior circulation. Lutsep et al. [27] described
one patient out of 109 with a presumed anterior circulation stroke
that was relocalized to the pons after MRI, leading to vascular
imaging, which revealed basilar stenosis, prompting a decision to
recommend anticoagulation. Albers et al. [28] described a single
patient in their series of 40 who was initially suspected to have a
lacunar infarct until MRI revealed a cortical localization, inducing
the treating doctors to order a transthoracic echocardiogram (TTE)
that would not have been obtained if MRI had confirmed a lacunar
infarct. The TTE demonstrated a large patent foramen ovale and
the patient was placed on anticoagulation because of a clinical
suspicion of paradoxical embolus.
Improved stroke localization was not the only way in which
MRI provided information regarding stroke mechanism. Shuaib
et al. [26] identified one patient whose MRI detected an unantici-
pated acute carotid thrombus, leading the treating doctors to initi-
ate anticoagulation. Wardlaw et al. [30] found that MRI identified
both primary intracerebral haemorrhage and recent infarct with
haemorrhagic transformation more commonly than CT, resulting
in altered antithrombotic management in 14 out of the 232 enrolled
patients, including five patients where MRI identified ICH that
was not detected on CT.
The superiority of MRI over CT, with respect to determining the
age of an infarct, led to changes in management in at least one of
the patients reported by Albers et al. [28]. That patient presented
with new focal neurologic symptoms initially thought to be the
consequence of a new infarct, but subsequently classified as
unmasking of old stroke symptoms based on MRI results. Conse-
quently, the patient was continued on warfarin monotherapy (for
known atrial fibrillation) instead of starting an additional antiplate-
let agent as was planned at the time of initial clinical assessment.
Zhao et al. [34] also used MRI to clarify the age of infarcts. By
treating all patients with hyperacute MRI findings who presented
within 12 hours from onset, 39 patients who would not have
received IV thrombolysis based on a conventional time-based
treatment strategy received thrombolysis.
Study quality
We evaluated study quality using the QUADAS instrument (Sup-
porting Information Appendix S3). With respect to this standard,
quality varied considerably between studies. The two most
common methodological limitations were inclusion of the index
test in the reference diagnostic standard and failure to report
withdrawals from the study. Many of the examples of manage-
ment changes cited in the studies were inconsistent with the most
recent evidence-based guidelines [35,36], but this is not surpris-
ing given that most of the studies were published more than 5
years ago.
Discussion
This systematic review identified almost no direct evidence that
MRI affects outcome in patients with stroke, and limited evidence
– derived from a small number of studies – that MRI affects
management. Of the 1813 screened articles, only nine explicitly
discussed how MRI findings influence management and only one
of these (a small case series) provided evidence suggesting that
Minimize
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Initiate
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Change
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Figure 2 Summary of management changes identified in included
articles.
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MRI findings contribute to improved patient outcomes. All iden-
tified studies were single-centre series; we found no randomized
controlled trials (RCTs), cohort studies or case-control studies that
addressed our specific study question. Many of the examples of
management changes cited in the nine studies were inconsistent
with the most recent evidence-based guidelines [35,36]. This
modest evidence base does not justify the routine use of MRI in
situations where the diagnosis of stroke is unequivocal.
Even though we did not find evidence from strong study designs
that MRI findings translate into changes in management or
improved outcomes, the studies included in our review illustrate
possible pathways linking MRI to outcomes. Specifically, they
provide examples in which MRI information about diagnosis,
stroke location or timing led clinicians to change management.
These suggestive examples merit more extensive and rigorous
investigation. If confirmed, they could point the way to more
effective stroke management algorithms and improved patient
selection for MRI. Given the high prevalence of stroke and the cost
of MRI, the clinical and public policy implications could be
substantial.
The value of this additional MRI-derived information cannot be
determined simply by evaluating sensitivities and specificities
without also studying how the additional information translates
into changes in management. The ideal would be to perform RCTs,
but these studies may not be practical for stroke MRI given that
MRI is now considered routine by many clinicians and given the
cost required to follow large number of stroke patients over an
extended interval.
Some of the studies included in our review provide examples of
study designs that might serve as alternatives to RCTs. In particular,
the vignette-based approaches of Wardlaw et al. and Schulz et al.
illustrate the advantages of requiring clinicians to state how they
would manage patients based on real-world cases, first without and
then with knowledge of MRI results. With this study design,
patients serve as their own controls, the exposure of interest can be
precisely controlled, and the use of consecutive real-world cases
allows for estimates of how frequently management is changed in
practice. Limitations include the artificial nature of the case abstrac-
tion and the decision-making environment. Some of these limita-
tions can be circumvented using a study design similar to that of
Albers et al. [28], requiring the treating clinicians to commit to an
explicit diagnostic impression and management plan immediately
before and immediately after obtaining an MRI. Neither vignette-
based studies nor pre-MRI/post-MRI surveys of treating doctors
can directly assess clinical outcomes, but they could provide the
background information necessary to perform simulation studies.
Our review had several limitations. First, although our search
criteria were designed to be as broad as possible, they may have
failed to identify some articles that would meet our inclusion
criteria. Second, we only included studies that provided explicit
examples of how MRI information altered management. Thus,
studies were excluded if management changes were only implicit.
Third, study methodology varied widely. Most notably, some
included studies compared MRI to CT and others compared MRI
techniques. Finally, we can not draw any conclusions regarding the
role of multi-modal MRI [e.g. magnetic resonance angiography
(MRA) or MR perfusion] because we included only studies in
which the management changes were based on structural MRI of
the brain parenchyma.
These limitations actually reinforce our conclusion that the avail-
able evidence is insufficient to determine the appropriate role of
stroke MRI. Its use is justified when the diagnosis of stroke is
unclear [11], but the limited evidence base linking MRI to changes
in management or outcomes calls into question the routine use of
stroke MRI in all stroke patients. Of course, the absence of evidence
relating MRI to outcomes is not evidence of no effect. The nine
studies identified in this review do tend to support the common
impression that MRI provides information (not available from CT)
that influences management in some stroke scenarios. Unfortu-
nately, these studies do not justify general inferences regarding how
often this is the case, or in what circumstances. Despite the substan-
tial methodological difficulties inherent in investigating these ques-
tions more rigorously, the clinical and policy implications are great
enough to justify the effort that will be required.
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